Lucida Medical

Lucida Medical develops cutting edge AI software that supports radiologists in detecting and diagnosing prostate cancer using MRI. Founded by experts in cancer imaging and AI, the company’s flagship tool, Pi™, is a CE marked medical device designed to match the accuracy of specialist radiologists. Its core team includes a blend of clinical and technical leadership—from experienced consultant radiologists and AI researchers to seasoned CEOs and engineering leaders. Backed by a distinguished advisory board, Lucida Medical combines deep scientific insight with practical clinical application to enhance workflow efficiency, reduce unnecessary investigations and support early intervention. Its solutions are validated against real‑world data and proven in multi centre NHS studies, reflecting a firm commitment to transforming prostate cancer pathways with intelligent, evidence based innovation.